SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NATCO PHARMA

BSE: 524816 30 Sep 2025
Healthcare
₹ 798.95
Natco Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

NATCO PHARMA - Share Price & Details

Market Cap
₹14,700
High /Low
1,505 / 660.0
Stock P/E
8.66
Book Value
₹425.0
Dividend Yield
0.73
ROCE
32.8
ROE
₹28.0
Face Value
2.0
PEG Ratio
0.06
EVEBITDA
₹5.49
Debt
279
CMP / FCF
15.6
Debt to equity
₹0.04
NP Ann
1,883
High price all time
1,639
Piotroski score
₹8.0
Graham Number
952.0
No. Eq. Shares
17.9
Net CF
₹49.6
Net profit
1,695
Price to book value
1.93
Interest Coverage
₹95.0
Low price all time
7.6
Industry PE
33.0
Reserves
₹7,571
Free Cash Flow
₹1,300

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
30 May 2025 ICICI Securities Hold ₹883.45 ₹890 0.7% moneycontrol View
13 Aug 2024 ICICI Securities Hold ₹1,475.55 ₹1,430 0% moneycontrol View
27 Mar 2024 Geojit Financial Services Buy ₹972 ₹1,116 -21.9% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
NATCO PHARMA LTD.12523.04641.011927.025.9114,7008.66
Rainbow Children's Medicare Li3540.33517.23347.485.091383053.7
GRANULES INDIA LTD.8233.6694.858102.082.861251926.2

Peer Comparison Chart


About NATCO PHARMA

Natco Pharma Ltd., with Security Code 524816, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Pharma stocks led by Natco, Wockhardt fall up to 5% after US tariffs on generic, patented drugs

(26 Sep 2025)
Indian Pharma companies, from Sun Pharma Ltd. to Aurobindo Pharma Ltd., Gland Pharma Ltd., Lupin Ltd., Cipla Ltd. among others fell up to 5%...
Read more →

Pharma stock in focus after board approves evaluation of agro business demerger

(26 Sep 2025)
Synopsis: NATCO Pharma approves in-principle evaluation of Agro business demerger to unlock pharmaceutical value, enhance growth,...
Read more →

Natco Pharma shares dive 20% post Q3 earnings. Details here

(22 Sep 2025)
Shares of Natco Pharma Ltd fell sharply in Thursday's trade after the company reported a 38 per cent, year-on-year (YoY), decline in its December 2024...
Read more →

Natco Pharma Rises 3.2% as USFDA Grants VAI to Kothur

(18 Sep 2025)
Mumbai, 18 September 2025: Natco Pharma Limited (NSE: NATCOPHARM, BSE: 524816) saw its shares jump 3.23%, trading at ₹884.90 at 1:27 pm IST...
Read more →

Natco Pharma Ltd soars 2.93%, rises for third straight session

(18 Sep 2025)
Natco Pharma Ltd is quoting at Rs 882.35, up 2.93% on the day as on 12:49 IST on the NSE. The stock is down 41.76% in last one year as...
Read more →

Natco Pharma Kothur Unit USFDA Status

(18 Sep 2025)
New Delhi, Sep 18 (PTI) Natco Pharma Ltd on Thursday said it has received an establishment inspection report from the US health regulator...
Read more →